HIV and African American People

Data for 2020 should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing, care-related services, and case surveillance activities in state and local jurisdictions. While 2020 data on HIV diagnoses and prevention and care outcomes are available, we are not updating this web content with data from these reports.

Black/African American^apeople account for a higher proportion of new HIV diagnoses and people with HIV, compared to other races and ethnicities. Racism, HIV stigma, homophobia, poverty, and barriers to health care continue to drive these disparities. Get the latest data on HIV among African American people and find out how CDC is making a difference.

HIV Risk Behaviors

PrEP Coverage

HIV Incidence

HIV Diagnoses

Knowledge of Status

Viral Suppression

Prevention Challenges

What Is the Impact of HIV on Racial and Ethnic Minorities in the U.S.?

HIV can affect anyone regardless of sexual orientation, race, ethnicity, gender, age, or where they live. However, in the United States, some racial/ethnic groups are more affected than others, compared to their percentage of the population. This is because some population groups have higher rates of HIV in their communities, thus raising the risk of new infections with each sexual or injection drug use encounter. Additionally, a range of social, economic, and demographic factors such as stigma, discrimination, income, education, and geographic region can affect people’s risk for HIV as well as their HIV-related outcomes.

Black/African American and Hispanic/Latino communities are disproportionately affected by HIV compared to other racial/ethnic groups. For example, in 2019, Blacks/African Americans represented 13% of the US population, but 40% of people with HIV. Hispanics/Latinos represented 18.5% of the population, but 25% of people with HIV.

Black/African American % of People with HIV, 2019: 40.3%. % of U.S. Population, 2019: 13.4%. White % of People with HIV, 2019: 28.5%. % of U.S. Population, 2019: 60.1%. Hispanic/Latino % of People with HIV, 2019: 24.7%. % of U.S. Population, 2019: 18.5%. Asian % of People with HIV, 2019: 1.5%. % of U.S. Population, 2019: 5.9%. American Indian/Alaska Native % of People with HIV, 2019: 0.3%. % of U.S. Population, 2019: 1.3%. Native Hawaiian and Other Pacific Islander % of People with HIV, 20... — *Source: CDC, Estimated HIV incidence and prevalence in the United States, 2015–2019, HIV Surveillance Supplemental Report 2021;26(1) and US Census Bureau, Quick Facts—United States.*

The disproportionate impact of HIV on Black/African American and Hispanic/Latino communities is also evident in incidence (new HIV infections), showing that effective prevention and treatment are not adequately reaching people who could benefit most.

Figure 3. HIV incidence by race/ethnicity, 2019 — *Source: CDC, Estimated HIV incidence and prevalence in the United States, 2015–2019, HIV Surveillance Supplemental Report 2021;26(1).*

Certain subpopulations within racial and ethnic minority groups are disproportionately affected as well. For example, gay, bisexual and other men who have sex with men (MSM) are by far the most affected group in the United States. They account for about 66% of new infections each year, even though they make up only 2% of the population, with the highest burden among Black and Latino gay and bisexual men. According to CDC, in 2019, 26% of new HIV infections were among Black gay and bisexual men, 23% among Latino gay and bisexual men, and 45% among gay and bisexual men under the age of 35.

Among women, disparities also exist. Black women are disproportionately affected by HIV as compared to women of other races/ethnicities. Although annual HIV infections remained stable overall among Black women from 2015 to 2019, the rate of new HIV infections among Black women is 11 times that of white women and four times that of Latina women.

Further, over 1 million people identify as transgender in the United States. In 2019, adult and adolescent transgender people composed 2% (669) of new HIV diagnoses in the United States and dependent areas. Most of those new HIV diagnoses were among Black/African American transgender women.

The National HIV/AIDS Strategy and Priority Populations

National HIV/AIDS Strategy for the United States, 2022-2025

The National HIV/AIDS Strategy (2022-2025) is the nation’s roadmap for ending the HIV epidemic in the U.S. by 2030. It recognizes racism as a serious public health threat that drives and affects both HIV outcomes and disparities. The Strategy highlights that while HIV remains a threat in every part of the United States, certain populations bear most of the burden, signaling where our HIV prevention, care, and treatment efforts must be focused. It therefore designates five priority populations: Gay, bisexual, and other men who have sex with men, in particular, Black, Latino, and American Indian/Alaska Native men; Black women; transgender women; youth aged 13-24 years; and people who inject drugs. The Strategy also set out targets for increasing to 95% the proportion of people with HIV in each of these priority populations who have a suppressed viral load. Learn more: View NHAS-at-a-Glance.

The NHAS Federal Implementation Plan also outlines federal agencies’ commitments to programs, policies, research, and activities designed to reduce HIV-related disparities and health inequities.

For in-depth information about the impact of HIV on different racial and ethnic populations, see these CDC fact sheets:

Risk by race/ethnicity

Risk by sexual orientation

For more information about the risk for different groups of people, see CDC’s HIV by Group, HIV in the United States and Dependent Areas and HIV in the United States by Region.

The Ryan White HIV/AIDS Program and Racial and Ethnic Minority

The Health Resources and Services Administration’s (HRSA) Ryan White HIV/AIDS Program (RWHAP) provides a comprehensive system of HIV primary medical care, medications, and essential support services for low-income people with HIV who are uninsured and underserved. The program serves more than half a million each year, comprising 50 percent of people with HIV in the United States.

Nearly three-quarters of RWHAP clients are from racial and ethnic minority populations. The percentage distribution of client populations by race/ethnicity has remained consistent since 2016. In 2021, approximately 46% of clients self-identified as Black/African American, 27% as White, 24% as Hispanic/Latino, and less than 2% each as American Indian/Alaska Native, Asian, Native Hawaiian/Pacific Islander, and people of multiple races. Further, in 2021, 89.7% of RWHAP clients receiving HIV medical care were virally suppressed, exceeding the national viral suppression average of 65.5% among all people with diagnosed HIV. This is a critical component of ending the HIV epidemic because people with HIV who take HIV medicine (called antiretroviral therapy or ART) as prescribed and get and keep an undetectable viral load can live long and healthy lives and will not transmit HIV to their HIV-negative partners through sex.

To learn more about HIV care outcomes for racial and ethnic minority clients and others served by the RWHAP program, view the RWHAP 2021 Annual Client-Level Data Report and the population-specific factsheets about clients served by the program.

Minority HIV/AIDS Fund

The U.S. Department of Health and Human Services’ Minority HIV/AIDS Fund is transforming HIV prevention, care, and treatment for communities of color by bringing federal, state, and community organizations together to design and test innovative solutions that address critical emerging needs and by working to improve the efficiency, effectiveness, and impact of federal investments in HIV programs and services for racial and ethnic minorities.

The Fund improves our national response to HIV in multiple ways, including through support for Ending the HIV Epidemic: A Plan for America, a federal initiative designed to reduce the number of new HIV infections in the United States by 75 percent over five years and 90 percent by 2030.

Read more about the Minority HIV/AIDS Fund.